Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1

Samms, Ricardo J., Smith, Dennis P., Cheng, Christine C., Antonellis, Patrick P., Perfield, James W., Kharitonenkov, Alexei, Gimeno, Ruth E., Adams, Andrew C.·2015·Cell Reports
DOI 10.1016/j.celrep.2015.04.046

Cited by (154)

Items 101–154 of 154

  1. Metabolic Effects of FGF-21: Thermoregulation and Beyond
    Bin Ni, Jared S. Farrar, Janina A. Vaitkus, Francesco Saverio Celi · 2015 · Frontiers in Endocrinology
  2. The autocrine role of FGF21 in cultured adipocytes
    Sarah Justesen, Kirsten V. Haugegaard, Jacob Bo Hansen, Harald Severin Hansen, Birgitte Andersen · 2020 · Biochemical Journal
  3. Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans
    Julie Mie Jacobsen, Natalia Petersen, Lola Torz, Marina Kjærgaard Gerstenberg, Kent Pedersen, Søren Østergaard, Birgitte Schjellerup Wulff, Birgitte Andersen, Kirsten Raun, Berit Østergaard Christoffersen et al. · 2024 · Cell Reports
  4. Prolonged FGF21 treatment increases energy expenditure and induces weight loss in obese mice independently of UCP1 and adrenergic signaling
    Sara Stanić, Kristina Bardová, Petra Janovská, Martin Rossmeisl, Ján Kopecký, Petr Zouhar · 2024 · Biochemical Pharmacology
  5. CREG1 stimulates brown adipocyte formation and ameliorates diet‐induced obesity in mice
    Michihiro Hashimoto, Tatsuya Kusudo, Tamaki Takeuchi, Naoya Kataoka, Takako Mukai, Hitoshi Yamashita · 2019 · The FASEB Journal
  6. Metabolic Factors Determining the Susceptibility to Weight Gain: Current Evidence
    Tim Hollstein, Paolo Piaggi · 2020 · Current Obesity Reports
  7. Hormonal and nutritional signalling in the control of brown and beige adipose tissue activation and recruitment
    Marta Giralt, Montserrat Cairó, Francesc Villarroya · 2016 · Best Practice & Research Clinical Endocrinology & Metabolism
  8. FGF21 decreases food intake and body weight in obese Göttingen minipigs
    Berit Østergaard Christoffersen, Ellen Marie Straarup, Kirsten Lykkegaard, Johannes Josef Fels, Kristian Sass‐Ørum, Xujia Zhang, Kirsten Raun, Birgitte Andersen · 2018 · Diabetes Obesity and Metabolism
  9. New concepts in the roles of AMPK in adipocyte stem cell biology
    Alice E Pollard · 2024 · Essays in Biochemistry
  10. Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator‐activated receptor γ coactivator‐1α‐deficient mice
    Justin A. Fletcher, Melissa A. Linden, Ryan D. Sheldon, Grace Margaret-Eleanor Meers, E. Matthew Morris, Anthony M. Butterfield, James W. Perfield, R. Scott Rector, John P. Thyfault · 2017 · Experimental Physiology
  11. Brown Adipose Expansion and Remission of Glycemic Dysfunction in Obese SM/J Mice
    Caryn Carson, Juan F Macias-Velasco, Subhadra C. Gunawardana, Mario A Miranda, Sakura Oyama, Celine L. St. Pierre, Heather K. Schmidt, Jessica P. Wayhart, Heather A. Lawson · 2020 · Cell Reports
  12. Exploring endocrine FGFs - structures, functions and biomedical applications
    Phuc Phan · 2024 · International Journal of Biochemistry and Molecular Biology
  13. Liver‐derived FGF21 is required for the effect of time‐restricted feeding on high‐fat diet‐induced fatty liver in mice
    Lun Hua, Jing Li, Yi Yang, Dandan Jiang, Xuemei Jiang, Xingfa Han, Chao Jin, Bin Feng, Lianqiang Che, Shengyu Xu et al. · 2023 · The FASEB Journal
  14. Attenuation of FGF21 signalling might aggravate the impairment of glucose homeostasis during the high sucrose diet induced transition from prediabetes to diabetes in WNIN/GR-Ob rats
    Suresh Kondeti, Dinesh Yadav D.M., Muralidhar MN, Prasad SMVK, Harishankar Nemani, Rajender Rao Kalashikam · 2021 · Biomedicine & Pharmacotherapy
  15. The Sum of All Browning in FGF21 Therapeutics
    Paul Lee, Michael M. Swarbrick, Jerry Richard Greenfield · 2015 · Cell Metabolism
  16. AAV‐mediated gene therapy as a strategy to fight obesity and metabolic diseases
    Carlos H. Sponton, Shingo Kajimura · 2018 · EMBO Molecular Medicine
  17. Endocrine and autocrine/paracrine modulators of brown adipose tissue mass and activity as novel therapeutic strategies against obesity and type 2 diabetes
    Marcel Scheideler, Stephan Herzig, Anastasia Georgiadi · 2017 · Hormone Molecular Biology and Clinical Investigation
  18. Dietary interventions and molecular mechanisms for healthy musculoskeletal aging
    Andrew William Murphy, Sagar S. Vyavahare, Sandeep Kumar, Tae Jin Lee, Ashok Kumar Sharma, Satish Adusumilli, Mark W. Hamrick, Carlos M. Isales, Sadanand Fulzele · 2022 · Biogerontology
  19. Skeletal muscle mitochondrial uncoupling prevents diabetes but not obesity in NZO mice, a model for polygenic diabesity
    Anja Voigt, Yvonne Katterle, Melanie Kahle, Reinhart Kluge, Annette Schürmann, Hans‐Georg Joost, Susanne Klaus · 2015 · Genes & Nutrition
  20. Beyond obesity – thermogenic adipocytes and cardiometabolic health
    Peter Aldiss, Neele S. Dellschaft, Harold S. Sacks, Helen Budge, Michael Edward Symonds · 2017 · Hormone Molecular Biology and Clinical Investigation
  21. Reduced adiposity attenuates FGF21 mediated metabolic improvements in the Siberian hamster
    Jo Edward Lewis, Ricardo J. Samms, Scott Cooper, Jeni Luckett, Alan Christopher Perkins, Andrew Charles Adams, Kostas Tsintzas, Francis J. P. Ebling · 2017 · Scientific Reports
  22. Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice
    Christopher S. Krumm, Xu Xu, Curtis J. Bare, Corey D. Holman, Sander Kersten, Lukas E. Dow, Ann-Hwee Lee, David E. Cohen · 2021 · Journal of Biological Chemistry
  23. Adipose Tissue T Regulatory Cells: Implications for Health and Disease
    David P. Bradley, Dharti Shantaram, Alan J. Smith, Willa A. Hsueh · 2021 · Advances in experimental medicine and biology
  24. The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review
    Agata Sadowska, Elżbieta Poniedziałek‐Czajkowska, Radzisław Mierzyński · 2023 · International Journal of Molecular Sciences
  25. Chloroquine attenuates diet-induced obesity and glucose intolerance through a mechanism that might involve FGF-21, but not UCP-1-mediated thermogenesis and inhibition of adipocyte autophagy
    Milene Ortiz‐Silva, Bianca Franco Leonardi, Érique Castro, Álbert S. Peixoto, Gustavo R. Gilio, Tiago E. Oliveira, Caroline Aparecida Tomazelli, Maynara Lucca Andrade, Mayara Franzoi Moreno, Thiago Belchior et al. · 2023 · Molecular and Cellular Endocrinology
  26. Interactions Between the Gravitostat and the Fibroblast Growth Factor System for the Regulation of Body Weight
    Vilborg Pálsdóttir, Sara H. Windahl, Daniel A. Hägg, Hanna Keantar, Jakob Bellman, Andrew G. Buchanan, Tristan J. Vaughan, Daniel Lindén, John‐Olov Jansson, Claes Ohlsson · 2019 · Endocrinology
  27. Obesity-resistance of UCP1-deficient mice associates with sustained FGF21 sensitivity in inguinal adipose tissue
    Marlou Klein Hazebroek, Susanne Keipert · 2022 · Frontiers in Endocrinology
  28. A Comprehensive Review on the Metabolic Cooperation Role of Nuclear Factor E2-Related Factor 2 and Fibroblast Growth Factor 21 against Homeostasis Changes in Diabetes
    Bahar Kiani, Sahar Yarahmadi, Mohsen Nabi‐Afjadi, Hanie Eskandari, Maryam Hasani, Zahra Abbasian, Elham Bahreini · 2022 · Clinical Diabetology
  29. The role of FGF21 in the metabolic adjustments required for exercise capacity
    Abe, Lisa, Dantzer, Robert · 2025 · Life Sciences
  30. Hyperphagia of female UCP1-deficient mice blunts anti-obesity effects of FGF21
    Marlou Klein Hazebroek, Rutger Laterveer, Maria Kutschke, Vida Ramšak Marčeta, Clarissa Souza Barthem, Susanne Keipert · 2023 · Scientific Reports
  31. Effects of swimming in cold water on lipolysis indicators via fibroblast growth factor-21 in male Wistar rats
    Sara Shams, Mostafa Tavasolian, Sadegh Amani-Shalamzari, Pezhman Motamedi, Hamid Rajabi, Katja Weiss, Beat Knechtle · 2024 · Biochemistry and Biophysics Reports
  32. Maternal obesity impairs fetal brown adipogenesis by attenuating fetal FGF21 signaling
    Lun Hua, Wen Shen, Dengfeng Gao, Yi Yang, Xiaohan Yang, Haoqi Zhang, Siyuan Liu, Luting Liu, Yaxue Cao, Xuemei Jiang et al. · 2025 · Cell Reports
  33. Mitochondrial Actions for Fat Browning and Energy Expenditure in White Adipose Tissue
    de Andrade PBM, Andressa Bolsoni Lopes, Maria Isabel Cardoso Alonso‐Vale · 2016 · Journal of Obesity and Overweight
  34. Animal Models for Manipulation of Thermogenesis
    John‐Paul Fuller‐Jackson, Iain James Clarke, Belinda A. Henry · 2017 · Elsevier eBooks
  35. FGF-21 Conducts a Liver-Brain-Kidney Axis to Promote Renal Cell Carcinoma
    Zongyu Li, Xinyi Zhang, Wanling Zhu, Cuiling Zhang, Katherine Sadak, Alexandra A. Halberstam, Jason Robert Brown, Curtis J. Perry, Azia Bunn, David A. Braun et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Pharmacological administration of FGF21 reverses obesity through a parabrachial-projecting neuron population in the hindbrain
    Yunfan Lin, Kristin E. Claflin, İltan Aklan, Donald A. Morgan, Andrew I. Sullivan, Michael C. Rudolph, Kamal Rahmouni, Matthew J. Potthoff · 2026 · Cell Reports
  37. Fibroblast Growth Factor 21 as a Regulator of Energy Metabolism in the Liver and Adipose Tissue
    Niina Matikainen, Sanni Söderlund · 2019 · Elsevier eBooks
  38. Lipid Response to Amino Acid Starvation in Fat Cells: Role of FGF21
    Albert Pérez‐Martí, Pedro F. Marrero, Diego Haro, Joana Relat · 2019 · Springer eBooks
  39. Growth factors reviews
    Xiaokun Li · 2024 · Elsevier eBooks
  40. AAV2-mediated ABD-FGF21 gene delivery produces a sustained anti-hyperglycemic effect in type 2 diabetic mouse
    Sen-lin Lu, Zhihao Pan, Zhi Gang Cui, Jili Wang, Jianlin Yang, Yafeng Lv, Chunyu Cao, Xiaofei Huang · 2024 · Life Sciences
  41. The Metabolic Effects of FGF21: From Physiology to Pharmacology
    Parkyong Song · 2020 · JoLS Journal of Life Sciences
  42. Regulation of Metabolism by Hepatic OXPHOS: A Dissertation
    Thomas E. Akie · 2015 · The Journal of the American Medical Association (JAMA) Network (American Medical Association)
  43. Lipid Response to Amino Acid Starvation in Fat Cells: Role of FGF21
    Albert Pérez‐Martí, Pedro F. Marrero, Diego Haro, Joana Relat · 2017 · Springer eBooks
  44. Role of Fsp27 in lípid homeostasis during nutrient deprivation
    Alexandra Carrilho do Rosario · 2018 · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
  45. Molecular description of fibroblast growth factor and mechanisms by which fibroblast growth factor-21 mediating biological actions and acting as a biologic biomarker of cardiovascular diseases
    Leta Shiferaw Melaku, Negeri Debela · 2020 · Indian Journal of Health Sciences and Biomedical Research (KLEU)
  46. Respostas do treinamento combinado sobre marcadores inflamatórios, metabólicos, autofágicos e de remodelamento do tecido adiposo em diabéticos tipo 2 com excesso de peso
    Ivan Luiz Padilha Bonfante · 2019
  47. ASK1 overexpression protects from HFD-induced body weight gain via FGF21
    Anne Goergen, Tenagne D. Challa, Marcela Borsigova, Carlos Villarroel-Vicente, Pim P. van Krieken, Stephan Wueest, Daniel Konrad · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Insulin-sensitizing effects of fibroblast growth factor-21 in underfed sheep
    Antonio Carlos Ramos dos Santos, Molly Mae McGuckin, Sarah L. Giesy, Yves R. Boisclair · 2025 · Journal of Animal Science
  49. NOVEL APPROACHES IN OBESITY TREATMENT: THE PROMISE OF GENE THERAPIES
    Karolina Błądzińska, Anna Opalińska, Cezary Lubas, Paula Folta, Kacper Szeląg, Joanna Kłosowska, Maciej Błądziński, Małgorzata Zach, Piotr Świerczek, Antoni Kujawski · 2025 · International Journal of Innovative Technologies in Social Science
  50. Impact de la déficience en acides aminés indispensables sur le métabolisme protéique et énergétique, et identification de signatures métaboliques
    Joanna Moro · 2021 · theses.fr (ABES)
  51. Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
    Zara Siu Wa Chui, Yaqian Xue, Xiaoping Wu, Aimin Xu · 2026 · Pharmacological Reviews
  52. ASK1 ‐Induced FGF21 Synthesis in the Liver Prevents Obesity in Mice
    Anne Goergen, Tenagne D. Challa, Carlos Villaroel‐Vicente, Marcela Borsigova, Pim P. van Krieken, Christian Wolfrum, Matthias Blüher, Stephan Wueest, Daniel Konrad · 2026 · Obesity
  53. Chronic Dopamine D1 Receptor Agonist Treatment Selectively Upregulates Hepatic Lipogenic Gene Expression Without Altering Thermogenesis
    Francesca Raffaelli, Rebecca Oelkrug, Karl Alexander Iwen, Jens Mittag · 2026 · Zenodo (CERN European Organization for Nuclear Research)
  54. Biological functions and emerging interplay of FGF21 and GDF15 in metabolic diseases and aging
    Laura Salmón‐Gómez, Susanne Keipert, Victoria Catalán, Amaia Rodrı́guez, Sara Becerril, Gema Frühbeck, Javier Gómez‐Ambrosi · 2026 · Molecular Biomedicine